The SPIOMET4HEALTH Final Project Meeting is currently taking place in Bologna, Italy, marking an important milestone after four years of research into Polyendocrine Metabolic Ovarian Syndrome (PMOS), previously known as polycystic ovary syndrome (PCOS).
Chris Mann and Joan Cabellos from ASPHALION are participating in the meeting, presenting the results of our work as the project’s regulatory partners and sharing insights into the regulatory pathway followed throughout the project.
With clinical sites across five European countries, SPIOMET4HEALTH has brought together an international research effort to generate evidence that could help improve the understanding, management and treatment of PMOS in adolescent girls and young women across Europe.
A valuable opportunity to share results, exchange knowledge and discuss the project’s impact on future clinical practice, research and policy.
Need help for your Horizon Europe projects? Contact us at: [email protected]
